# GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
Canonical URL: https://biopharmsignal.com/news/WGS/genedx-to-report-first-quarter-2024-financial-results-on-monday-april-29-2024-9679878c
Ticker: WGS
Company: GeneDx
Source: GeneDx
Published: 2024-04-04 20:05 EST
## Summary

Management will host a conference call on Monday, April 29, 2024 to discuss first quarter 2024 financial and operating results at 4:30 p.m. Eastern Time. ...

## Article Body
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the first quarter of 2024 after the market closes on Monday, April 29, 2024. Management will host a conference call that day to discuss first quarter 2024 financial and operating results at 4:30 p.m. Eastern Time.

Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the “Events” section of the GeneDx investor relations website at https://ir.genedx.com/ .

About GeneDx At GeneDx (Nasdaq: WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It all starts with a single test. For more information, please visit genedx.com and connect with us on LinkedIn , X , Facebook , and Instagram .

Investor Relations Contact: investors@GeneDx.com

Media Contact: press@GeneDx.com
## Recent Company News
- 2024-07-11 20:05 EST — [GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024](https://biopharmsignal.com/news/WGS/genedx-to-report-second-quarter-2024-financial-results-on-tuesday-july-30-2024-4818bc73) — Source: GeneDx
- 2024-06-10 12:30 EST — [GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients](https://biopharmsignal.com/news/WGS/genedx-announces-collaboration-with-epic-aura-to-expand-access-to-rapid-whole-ge-740de912) — Source: GeneDx
- 2024-06-05 11:00 EST — [GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients](https://biopharmsignal.com/news/WGS/genedx-announces-patient-access-program-to-expand-access-to-exome-testing-for-pe-c4b289d2) — Source: GeneDx
- 2024-05-22 20:05 EST — [GeneDx to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/WGS/genedx-to-participate-in-upcoming-investor-conferences-5e6d9364) — Source: GeneDx
- 2024-04-29 20:05 EST — [GeneDx Reports First Quarter 2024 Financial Results and Business Highlights](https://biopharmsignal.com/news/WGS/genedx-reports-first-quarter-2024-financial-results-and-business-highlights-6b87f4af) — Source: GeneDx
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)